KVUE:NYSE
Kenvue Inc
$17.81
arrow_downward
-0.34%(-0.060) 1D
$17.83
arrow_upward
+0.12% (+0.021)bedtimeAfter hours
Closed: Sep 18, 4:00:04 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KVUE...
Open
$17.80
High
$17.97
Low
$17.76
Mkt. cap
34.21B
Avg. vol.
24.44M
Volume
26.72M
Dividend
4.72%
Quarterly dividend
$0.21
Ex-dividend date
Sep 21, 2026
P/E ratio
20.65
52-wk high
$20.13
52-wk low
$14.02
EPS
$0.86
Beta
0.46
Shares outstanding
1.92B
No. of employees
22K
Open
$17.80
High
$17.97
Low
$17.76
Mkt. cap
34.21B
Avg. vol.
24.44M
Volume
26.72M
Dividend
4.72%
Quarterly dividend
$0.21
Ex-dividend date
Sep 21, 2026
P/E ratio
20.65
52-wk high
$20.13
52-wk low
$14.02
EPS
$0.86
Beta
0.46
Shares outstanding
1.92B
No. of employees
22K
News stories
From web sources and news partners
ad-hoc-news.de
·
2 days ago
Kenvue stock heads into the open after closing near USD 17.97
ad-hoc-news.de
·
2 days ago
Kenvue stock holds near USD 17.97 as takeover chatter builds
CarePlus VietNam
·
1 month ago
KVUE Q2 2026 Earnings: EPS Misses Consensus by 4.79% Amid Consumer Health Pressures - Earnings Season Review
CarePlus VietNam
·
1 month ago
KVUE Q1 2026 Earnings: EPS Beats Estimates by 19.6% as Stock Edges Down 0.36% - Slow Growth Warning
Profile
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
About Kenvue Inc
CEOKirk Perry
Employees21.9K
FoundedFeb 23, 2022
HeadquartersSummit, New Jersey, United States
SectorPersonal care products
Websitekenvue.com